Skip to main content

Breadcrumb

  1. Home

Endorsed

Cervical Cancer Screening

  • The percentage of women 21–64 years of age who were screened for cervical cancer using either of the following criteria:
    -Women 21–64 years of age who had cervical cytology performed within the last 3 years.
    -Women 30–64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years.
    -Women 30–64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) cotesting within the last 5 years.

    CBE ID
    0032

Child Hospital Consumer Assessment of Healthcare Providers and Systems (Child HCAHPS) Survey

  • The Child Hospital Consumer Assessment of Healthcare Providers and Systems (Child HCAHPS) Survey is a standardized survey instrument that asks parents and guardians (henceforth referred to as parents) of children under 18 years old to report on their and their child’s experiences with inpatient hospital care.

    The performance measures of the Child HCAHPS survey consist of 39 items organized by overarching groups into the following 18 composite and single-item measures:


    Communication with Parent
    1. Communication between you and your child’s nurses (3 items)

    CBE ID
    2548

Childhood Immunization Status (CIS)

  • Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DtaP); three polio (IPV); one measles, mumps and rubella (MMR); three haemophilus influenza type B (HiB); three hepatitis B (HepB); one chicken pox (VZV); four pneumococcal conjugate (PCV); one hepatitis A (HepA); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday. The measure calculates a rate for each vaccine.

    CBE ID
    0038

Chlamydia Screening in Women (CHL)

  • The percentage of women 16–24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year.

    CBE ID
    0033

Clinician-Level and Clinician Group-Level Total Hip Arthroplasty and/or Total Knee Arthroplasty (THA and TKA) Patient-Reported Outcome-Based Performance Measure (PRO-PM)

  • This patient-reported outcome-based performance measure uses the same measure specifications as the NQF-endorsed (NQF # 3559) hospital-level risk-standardized improvement rate (RSIR) following elective primary THA/TKA with the following exception: this measure attributes the outcome to a clinician or clinician group. Specifically, this measure will estimate a clinician-level and/or a clinician group-level RSIR following elective primary THA/TKA for Medicare fee-for-service (FFS) patients 65 years of age and older.

    CBE ID
    3639

CollaboRATE Shared Decision Making Score

  • CollaboRATE is a patient-reported measure of shared decision making which contains three brief questions that patients, their parents, or their representatives complete following a clinical encounter. The CollaboRATE measure provides a performance score representing the percentage of adults 18 and older who experience a high level of shared decision making.

    CBE ID
    3227